Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2019-02-16
2021-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intermittent Negative Pressure to Improve Blood Flow in Patients With Peripheral Artery Disease: Optimal Pulse Pressure Regime
NCT03547817
Intermittent Negative Pressure to Improve Blood Flow in Patients With Peripheral Artery Disease: Effects After Long-term Treatment
NCT03640676
Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes
NCT05009602
Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg
NCT01893840
Predicting Outcomes of PAD Patients Undergoing Endovascular Intervention With CTA
NCT03974880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active PAD group
-40mmHg of Intermittent Negative Pressure (INP) for 4-8 weeks.
Active Intermittent Negative Pressure (INP)
Application of -40mmHg negative pressure on the lower limb
Placebo PAD group
-10mmHg of Intermittent Negative Pressure (INP) for 4-8 weeks.
Placebo Intermittent Negative Pressure (INP)
Application of -10mmHg negative pressure on the lower limb
Healthy Volunteers
-40 mmHg of Intermittent Negative Pressure (INP) for 5 days
Active Intermittent Negative Pressure (INP)
Application of -40mmHg negative pressure on the lower limb
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Intermittent Negative Pressure (INP)
Application of -40mmHg negative pressure on the lower limb
Placebo Intermittent Negative Pressure (INP)
Application of -10mmHg negative pressure on the lower limb
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Attending vascular outpatient clinics or admitted in ward with PAD.
* ABPI \<0.9
Healthy Volunteers:
* Age ≥ 18 years
* No current or previous significant cardiovascular illness
* Able to give written informed consent
Exclusion Criteria
* Unable to give written informed consent
* Patients with deep venous thrombosis
* Pregnant women
Healthy Volunteers:
* Positive medical history of: Vascular diseases such as PAD, stroke, IHD, hypertension... etc.
* Haematological conditions such as hypercoagulability, deep venous thrombosis... etc.,
* Alcohol excess
* Unable to give written informed consent
* Pregnant women
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Dundee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jody McIntosh
Role: PRINCIPAL_INVESTIGATOR
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Medicine, University of Dundee, Ninewells Hospital & Medical School
Dundee, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-014-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.